← Open Payments lookup

ROBERT BROWN: Open Payments

NPI 1487610879 · MINDEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,443 in 76 payments from 16 companies in 2025. Trend: 2023 $767 · 2024 $640 · 2025 $1,443

Food & beverage: $1,355Education: $89
CompanyPaymentsAmount
ABBVIE INC.16$248
Alkermes, Inc.13$166
Bayer Healthcare Pharmaceuticals Inc.9$155
Axsome Therapeutics, Inc.9$148
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$130
Otsuka America Pharmaceutical, Inc.4$100
Vanda Pharmaceuticals Inc.2$100
Astellas Pharma US Inc1$85
Novo Nordisk Inc3$53
Takeda Pharmaceuticals U.S.A., Inc.3$48

Products named: VRAYLAR, ARISTADA, Kerendia, Auvelity, REXULTI, CAPLYTA, FANAPT, TRINTELLIX.

Industry payments across LA — which companies pay providers there.